Davis Todd C bought LGND
March 25, 2024 · Form 4 insider transaction
Davis Todd C bought 2,855 shares of Ligand Pharmaceuticals Incorporated at $67.24 per share, a transaction worth $192.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,855
Price
$67.24
Total value
$192.0K
InsiderDavis Todd C
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 25, 2024
Filing dateMarch 27, 2024
Shares owned after114,448
OwnershipDirect
10b5-1 planNo
AmendedNo